Skip to main content
main-content
Top

09-23-2020 | EASD 2020 | Conference coverage | News

Non-invasive technique detects residual beta cells in longstanding diabetes

Author:
Eleanor McDermid

medwireNews: A non-invasive imaging technique could make it possible to determine if people with longstanding type 1 diabetes have residual beta cells, researchers have reported at the virtual 56th EASD Annual Meeting.

The team identified residual beta cells via detection of the glucagon-like peptide (GLP)-1 receptor, using the stable GLP-1 analog exendin-4, radiolabeled for imaging purposes.

Marti Boss (Radboud University Medical Center, Nijmegen, the Netherlands) reported that they found a small amount of tracer uptake in all 10 people with type 1 diabetes of at least 5 years’ duration included in their study. Further investigation suggested that some of this background tracer uptake was due to the expression of GLP-1 receptor on non-insulin-producing delta cells.

Nevertheless, although exendin-4 uptake was significantly lower overall in the people with diabetes than in 10 healthy volunteers, six people had uptake that was “in the lower half of the range of the uptake in the healthy individuals,” said Boss.

This did not correlate with levels of plasma C-peptide, which was detectable in just two of the people with diabetes. “So it seems that we’re actually looking at residual dysfunctional beta-cell mass here,” noted Boss.

Supporting these findings in living people, 12 of 19 postmortem pancreas samples from people with longstanding type 1 diabetes contained limited numbers of cells that stained positive for both insulin and GLP-1 receptor.

“It seems that we can use GLP-1 receptor imaging to see residual beta cells in people with type 1 diabetes, and really see differences between beta-cell mass in different patients,” concluded Boss.

“And therefore we can use GLP-1 receptor imaging for non-invasive imaging of beta-cell mass and it’s actually a very valuable tool to further understand the pathophysiology of type 1 diabetes.”

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2020 Springer Healthcare Ltd, part of the Springer Nature Group

EASD virtual meeting; 21–25 September 2020

Addressing suicide risk in diabetes

07-14-2021 | Mental health | Feature | Article

Suicide in diabetes: An important but under-recorded problem

How frequent are suicide deaths in people with diabetes, and can the data be trusted?

07-14-2021 | Mental health | Feature | Article

Risk for suicidal ideation: Who, when, and why?

What makes some people more likely than others to have suicidal thoughts? We outline the risk factors and circumstances that can play a role.

07-14-2021 | Mental health | Feature | Article

Creating a safety net: How doctors can help suicidal patients

Screening, emergency protocols, and person-centered care – just some of the ways healthcare professionals can identify and support people at increased risk for suicide. Click through for more.

Suicide risk in diabetes: Why doctors may hesitate to screen, but should not

ESC Congress 2021 coverage

27 – 30 August: Browse all of the latest coverage